Małopolskie Centrum Sercowo-Naczyniowe AhoP
- Address
- Ul. Topolowa 16, 32-500 Chrzanow, Poland
Małopolskie Centrum Sercowo-Naczyniowe AhoP
Małopolskie Centrum Sercowo-Naczyniowe AhoP is a specialized cardiovascular research center focused on advancing interventional cardiology and vascular medicine. The center conducts innovative clinical trials evaluating novel therapeutic approaches for patients with cardiovascular and peripheral vascular diseases, with particular emphasis on percutaneous coronary interventions and endovascular treatments.
- Lower extremity artery disease (LEAD) and prevention of restenosis following stent placement in superficial femoral artery
- Acute coronary syndrome management and optimization of post-PCI outcomes
- Investigation of pharmacological interventions including colchicine and metformin for cardiovascular protection
The research center demonstrates expertise in evaluating both drug-eluting stent technologies and adjunctive oral pharmacotherapy to improve long-term outcomes in patients undergoing vascular interventions. Their clinical trials portfolio reflects a commitment to evidence-based medicine, combining cutting-edge interventional techniques with innovative medication strategies to reduce restenosis rates and prevent unplanned revascularization procedures in cardiovascular patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Małopolskie Centrum Sercowo-Naczyniowe AhoP
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Oct 2021 | Jan 2025 |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 765845 | 1 | Unknown | 2023-11-27 | 2023-11-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.